Clinical Trial Update: Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder [Phase 4]

View source ↗

Summary

A Phase 4 community-based trial comparing extended-release methylphenidate and atomoxetine in children with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)
• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED